MONTREAL, May 1 /PRNewswire-FirstCall/ - LMS Medical Systems (TSX: LMZ, AMEX: LMZ), a healthcare technology company and developer of the CALM- patient safety software system for obstetrics, today announced that its Board of Directors has unanimously decided to delist the Company's common shares from Amex.
The decision is in keeping with the Company's previous announcement to streamline operations and control costs in order to become cash flow positive. It is expected that Amex trading will cease on or about May 22, 2008.
LMS common shares will continue to be traded on the Company's principal exchange, the TSX.
About LMS: LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM Suite provides physicians, nursing staff, risk managers and hospital administrators with clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth.
Except for historical information contained herein, the matters
discussed in this news release are forward-looking statements. Because
these forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed implied by the forward-looking statements including, but
without limitation, economic conditions in general and in the healthcare
market, the demand for and market for our products in domestic and
international markets, our current dependence on the CALM product suite,
the challenges associated with developing new products and obtaining
regulatory approvals if necessary, research and development activities, the
uncertainty of acceptance of our products by the medical community, the
lengthy sales cycle for our products, third party reimbursement,
competition in our markets, including the potential introduction of
competitive products by others, our dependence on our d
|SOURCE LMS MEDICAL SYSTEMS INC.|
Copyright©2008 PR Newswire.
All rights reserved